Sciex Collaborate on Major Proteomic Mapping Project
Sciex has announced that it will work with the Francis Crick Institute and the University of Cambridge to build a metabolism-centric proteomic map.
Sciex (Massachusetts, USA) has announced that it will work with the Francis Crick Institute (London, UK) and the University of Cambridge (Cambridge, UK) to build a metabolism-centric proteomic map.
The comprehensive map will focus on enzymes involved in the control of metabolism and will be developed using Sciex micro-flow chromatography and data-independent Swath acquisition.
David Roblin, Chief Operating Officer and Director of Scientific Translation at the Francis Crick Institute, expressed delight at the collaboration and highlighted the support received from the Biotechnology and Biological Sciences Research Council (BBSRC) UK. “The grant from the BBSRC demonstrates that the multidisciplinary nature of the Crick is creating new scientific ideas that are leading to translation and commercial opportunities. This accelerated translation of our science for health and wealth benefits is a key feature of our strategy,” said Roblin.
The project aims to address a growing demand from the biotechnology industry for fast and robust large-scale proteome analysis to further our understanding of the function and activity of the metabolic network, providing insights into its effect on ageing and age-associated diseases.
“Gaining and sharing knowledge around the ageing process has great potential for unlocking answers to the questions of precision medicine,” said Chris Radloff, Global Vice President & General Manager of the LC–MS Business at Sciex.
The emergence of precision medicine for disease treatment and prevention has highlighted the need for industrialized proteomics, which allows faster analysis of larger sample sets than the current, widely-used omic methods.
The study will be led by Dr. Markus Ralser of the Francis Crick Institute and Professor Kathryn Lilley from the University of Cambridge.
For more information please visit www.sciex.com.
Simultaneous Screening of Pesticide Residues in Date Fruits with UHPLC–MS/MS and GC–MS/MS
March 7th 2025Comprehensive information was derived through the utilization of a QuEChERS-UHPLC–MS/MS and GC–MS/MS method for the detection of 211 volatile and stable pesticide residues in 90 date fruit samples.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
Pick Your Poison. Isolation of Paclitaxel (Mar 2025)
March 7th 2025The diterpenoid, paclitaxel, which was identified as a potent chemotherapy agent for breast and ovarian cancer originates from the Pacific Yew tree. The isolation of paclitaxel from its major impurities is shown with the use of Hamilton’s PRP-1 (5 µm) HPLC column.
